XML 31 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Series A Convertible Preferred Stock
Preferred Stock
Series B Convertible Preferred Stock
Preferred Stock
Series C Convertible Preferred Stock
Exchangeable Shares
Proportionate Voting Shares
Common Shares Equivalent
Additional Paid In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Controlling Interest
Balance at Dec. 31, 2019 $ 54,750               $ 231,637 $ (787) $ (182,561) $ 6,461
Balance, shares at Dec. 31, 2019   66,563,322       38,890,571 75,417 180,870,422        
Shares issued - stock options, warrant and RSU exercises 8,448               8,448      
Shares issued - stock options, warrant and RSU exercises, shares   3,203,470           3,203,470        
Shares issued- compensation for services 3,750               3,750      
Shares issued - compensation for services, shares   1,625,701           1,625,701        
Private placement net of share issuance costs 23,977               23,977      
Private placement net of share issuance costs, shares   5,313,786 15,239 3,440       23,992,786        
Shares issued- conversion, shares   2,820,506 (981) (2,730)     890          
Issuance of warrants 27,177               27,177      
Share-based compensation expense 10,475               10,475      
Options and warrants expired/forfeited                 (3,171)   3,171  
Modification of warrants associated with RIV Capital debt 2,845               2,845      
Capital (distributions)/contributions 393                     393
Net (loss) income for the year (142,256)                   (139,204) (3,052)
Foreign currency translation (2,875)                 (2,875)    
Balance at Dec. 31, 2020 (13,316)               305,138 3,662 (318,594) 3,802
Balance, shares at Dec. 31, 2020   79,526,785 14,258 710   38,890,571 76,307 209,692,379        
Shares issued - stock options, warrant and RSU exercises 50,000               50,000      
Shares issued - stock options, warrant and RSU exercises, shares   10,172,500     123,000     10,295,500        
Shares, options and warrants issued- acquisitions 34,427               34,427      
Shares, options and warrants issued - acquisitions, shares   3,464,870           3,464,870        
Shares issued- liability settlement 80               80      
Shares issued- liability settlement, shares   8,000           8,000        
Private placement net of share issuance costs 173,477               173,477      
Private placement net of share issuance costs, shares   18,115,656           18,115,656        
Shares issued- conversion, shares   78,358,768 (550) (100) (87)   (76,307) 1,314,768        
Share-based compensation expense 14,941               14,941      
Options and warrants expired/forfeited                 (829)   829  
Investment in NJ partnership (48,878)               (47,472)     (1,406)
Conversion of convertible debt 5,656               5,656      
Conversion of convertible debt, shares   1,284,221           1,284,221        
Capital (distributions)/contributions (53)                     (53)
Net (loss) income for the year 6,135                   3,111 3,024
Foreign currency translation 6,485                 6,485    
Balance at Dec. 31, 2021 228,954               535,418 2,823 (314,654) 5,367
Balance, shares at Dec. 31, 2021   190,930,800 13,708 610 36 38,890,571   244,175,394        
Shares issued - stock options, warrant and RSU exercises 25,927               25,927      
Shares issued - stock options, warrant and RSU exercises, shares   10,633,857           10,633,857        
Shares, options and warrants issued- acquisitions 331,983               331,983      
Shares, options and warrants issued - acquisitions, shares   56,812,852       13,504,500   70,317,352        
Shares issued- liability settlement 264               264      
Shares issued- liability settlement, shares   101,203           101,203        
Shares issued- conversion, shares   1,145,819 (1,100) (10) (36)              
Shares issued- Canopy USA arrangement 55,520               55,520      
Shares issued- Canopy USA arrangement, shares           24,601,467   24,601,467        
Share-based compensation expense 12,162               12,162      
Options and warrants expired/forfeited                 (26,302)   26,302  
Capital (distributions)/contributions (7,550)                     (7,550)
Net (loss) income for the year (325,351)                   (329,908) 4,557
Foreign currency translation (738)                 (738)    
Balance at Dec. 31, 2022 $ 321,171               $ 934,972 $ 2,085 $ (618,260) $ 2,374
Balance, shares at Dec. 31, 2022   259,624,531 12,608 600   76,996,538   349,829,273